DudeDiligence.

SELLAS Life Sciences Group, Inc

SLSNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

Shares on issue

203.5M

From 57.8M in June 2024

a raise that quarter, at its price

Newest

No limit

S-3ASR of 2026-03-20. An automatic shelf: the form sets no dollar limit. 1 prospectus supplement filed under it since.

$150.0M

TD Securities (USA), agreement of 2026-03-20. No at-the-market sales on file.

Warrants

20K

Priced warrants: 20K at $1.88.

Cash

19.7 quarters

$134.7M cash on hand.

Raised
DateWhatSharesPriceGrossFiling
2026-11-18Public offering11,538,462$13.00$150.0M424B5 ↗
2025-10-24Public offeringnot available$1.535$31.0M424B5 ↗
2025-01-28Registered direct offering incl. 19.69M pre-funded27,885,040not available$25.0M8-K ↗
2025-01-28Public offering incl. 11.49M pre-funded19,685,040$1.27$25.0M424B5 ↗
2024-07-30Public offering incl. 9.48M pre-funded15,849,056$1.325$21.0M424B5 ↗
2024-07-30Registered direct offering incl. 15.85M pre-funded22,219,126not available$21.0M8-K ↗